# Yazen

> Digital obesity-care platform combining weight-loss medication with multidisciplinary clinical support.

## Why it is interesting

Yazen is testing whether GLP-1-era weight management can become a durable longitudinal-care business rather than a prescription-acquisition channel.

## Profile

- **Latest funding:** Growth financing — €50 million (October 8, 2026)
- **Latest known valuation:** Not publicly disclosed
- **Total disclosed equity funding:** Not publicly disclosed
- **Stage:** growth
- **Status:** private
- **Industries:** healthtech
- **Coverage:** full
- **Last updated:** 2026-10-09T02:03:00.000Z
- **Latest funding investors:** Verdane, Evli Growth Partners

## Key facts

- 50,000-plus active patients and 70,000-plus treated, according to the investor announcement.
- Operates in Sweden, Norway, Denmark, the Netherlands, the UK, Germany, Switzerland and Spain.

## Funding history

- Growth financing · €50 million · October 8, 2026
  Source: https://verdane.com/verdane-partners-with-digital-healthcare-provider-yazen/

## Investors in our directory

- https://venturecapitaltracker.com/fund/verdane
- https://venturecapitaltracker.com/fund/evli-growth-partners

## Related articles

- https://venturecapitaltracker.com/2026-yazen-50m-growth-obesity-care

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** October 9, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/startup/yazen